These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 18273537)
1. Reductions in qEEG slowing over 1 year and after treatment with Cerebrolysin in patients with moderate-severe traumatic brain injury. Alvarez XA; Sampedro C; Figueroa J; Tellado I; González A; García-Fantini M; Cacabelos R; Muresanu D; Moessler H J Neural Transm (Vienna); 2008 May; 115(5):683-92. PubMed ID: 18273537 [TBL] [Abstract][Full Text] [Related]
2. A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in vascular dementia: cognitive improvement correlates with qEEG acceleration. Muresanu DF; Alvarez XA; Moessler H; Buia M; Stan A; Pintea D; Moldovan F; Popescu BO J Neurol Sci; 2008 Apr; 267(1-2):112-9. PubMed ID: 18048059 [TBL] [Abstract][Full Text] [Related]
3. Persistence of the effects of Cerebrolysin on cognition and qEEG slowing in vascular dementia patients: results of a 3-month extension study. Muresanu DF; Alvarez XA; Moessler H; Novak PH; Stan A; Buzoianu A; Bajenaru O; Popescu BO J Neurol Sci; 2010 Dec; 299(1-2):179-83. PubMed ID: 20923712 [TBL] [Abstract][Full Text] [Related]
4. Positive effects of cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study. Alvarez XA; Sampedro C; Pérez P; Laredo M; Couceiro V; Hernández A; Figueroa J; Varela M; Arias D; Corzo L; Zas R; Lombardi V; Fernández-Novoa L; Pichel V; Cacabelos R; Windisch M; Aleixandre M; Moessler H Int Clin Psychopharmacol; 2003 Sep; 18(5):271-8. PubMed ID: 12920387 [TBL] [Abstract][Full Text] [Related]
7. [Cerebrolysin in the treatment of brain injuries of moderate severity]. Talypov AE; Myachin MY; Kuksova NS; Kordonsky AY Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):98-106. PubMed ID: 25591645 [TBL] [Abstract][Full Text] [Related]
8. A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease. Alvarez XA; Cacabelos R; Laredo M; Couceiro V; Sampedro C; Varela M; Corzo L; Fernandez-Novoa L; Vargas M; Aleixandre M; Linares C; Granizo E; Muresanu D; Moessler H Eur J Neurol; 2006 Jan; 13(1):43-54. PubMed ID: 16420392 [TBL] [Abstract][Full Text] [Related]
9. A retrospective, multi-center cohort study evaluating the severity- related effects of cerebrolysin treatment on clinical outcomes in traumatic brain injury. Muresanu DF; Ciurea AV; Gorgan RM; Gheorghita E; Florian SI; Stan H; Blaga A; Ianovici N; Iencean SM; Turliuc D; Davidescu HB; Mihalache C; Brehar FM; Mihaescu AS; Mardare DC; Anghelescu A; Chiparus C; Lapadat M; Pruna V; Mohan D; Costea C; Costea D; Palade C; Bucur N; Figueroa J; Alvarez A CNS Neurol Disord Drug Targets; 2015; 14(5):587-99. PubMed ID: 25924999 [TBL] [Abstract][Full Text] [Related]
10. Routine and quantitative EEG in mild traumatic brain injury. Nuwer MR; Hovda DA; Schrader LM; Vespa PM Clin Neurophysiol; 2005 Sep; 116(9):2001-25. PubMed ID: 16029958 [TBL] [Abstract][Full Text] [Related]
12. N-Pep-12 supplementation after ischemic stroke positively impacts frequency domain QEEG. Popa LL; Iancu M; Livint G; Balea M; Dina C; Vacaras V; Vladescu C; Balanescu L; Buzoianu AD; Strilciuc S; Muresanu D Neurol Sci; 2022 Feb; 43(2):1115-1125. PubMed ID: 34173086 [TBL] [Abstract][Full Text] [Related]
13. QEEG indices in traumatic brain injury - insights from the CAPTAIN RTMS trial. Olivia VR; Chira D; Chelaru VF; Diana CD; Livia LP; Buruiană AM; Mureşanu FD J Med Life; 2024 Mar; 17(3):318-325. PubMed ID: 39044922 [TBL] [Abstract][Full Text] [Related]
14. Quantitative electroencephalography power analysis in subjective idiopathic tinnitus patients: a clinical paradigm shift in the understanding of tinnitus, an electrophysiological correlate. Shulman A; Avitable MJ; Goldstein B Int Tinnitus J; 2006; 12(2):121-31. PubMed ID: 17260877 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trial. Muresanu DF; Florian S; Hömberg V; Matula C; von Steinbüchel N; Vos PE; von Wild K; Birle C; Muresanu I; Slavoaca D; Rosu OV; Strilciuc S; Vester J Neurol Sci; 2020 May; 41(5):1171-1181. PubMed ID: 31897941 [TBL] [Abstract][Full Text] [Related]
16. Quantitative EEG Parameters for Prediction of Outcome in Severe Traumatic Brain Injury: Development Study. Tolonen A; Särkelä MOK; Takala RSK; Katila A; Frantzén J; Posti JP; Müller M; van Gils M; Tenovuo O Clin EEG Neurosci; 2018 Jul; 49(4):248-257. PubMed ID: 29172703 [TBL] [Abstract][Full Text] [Related]
17. Beneficial effect of cerebrolysin on moderate and severe head injury patients: result of a cohort study. Wong GK; Zhu XL; Poon WS Acta Neurochir Suppl; 2005; 95():59-60. PubMed ID: 16463821 [TBL] [Abstract][Full Text] [Related]
18. [Electrophysiological correlates of efficacy of nootropic drugs in the treatment of consequences of traumatic brain injury in adolescents]. Iznak EV; Iznak AF; Pankratova EA; Zavadenko NN; Guzilova LS; Guzilova IuI Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 1):27-32. PubMed ID: 21322822 [TBL] [Abstract][Full Text] [Related]
19. Accelerated recovery from acute brain injuries: clinical efficacy of neurotrophic treatment in stroke and traumatic brain injuries. Bornstein N; Poon WS Drugs Today (Barc); 2012 Apr; 48 Suppl A():43-61. PubMed ID: 22514794 [TBL] [Abstract][Full Text] [Related]
20. Poststroke QEEG informs early prognostication of cognitive impairment. Schleiger E; Wong A; Read S; Rowland T; Finnigan S Psychophysiology; 2017 Feb; 54(2):301-309. PubMed ID: 28118690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]